银屑病瘙痒的神经元机制:IL-17R/ERK/TRPV4信号通路的作用
该研究在咪喹莫特诱导的小鼠银屑病模型中,发现DRG感觉神经元中IL-17RA和IL-17RC表达上调,条件性敲除Il17ra或Il17rc可减轻瘙痒。体外和体内实验表明IL-17RA/RC通过ERK通路上调TRPV4,删除Trpv4或抑制ERK磷酸化也能缓解瘙痒,提示该通路在银屑病瘙痒中起重要作用。
要点
- 感觉神经元IL-17RA/RC上调参与银屑病瘙痒
- IL-17R通过ERK通路上调TRPV4离子通道
- 靶向该通路可减轻银屑病样瘙痒
核心结论
- 感觉神经元中的IL-17R/ERK/TRPV4信号通路在银屑病瘙痒中发挥重要作用。
研究设计与样本
- 采用咪喹莫特诱导的小鼠银屑病模型,结合条件性基因敲除、体外培养神经元实验和体内动物实验。
主要发现
- 银屑病小鼠DRG神经元中IL-17RA和IL-17RC表达上调。
- 感觉神经元条件性敲除Il17ra或Il17rc可显著减轻银屑病样瘙痒。
- IL-17RA/RC通过ERK信号通路上调DRG神经元中的TRPV4。
- 特异性删除Trpv4或抑制ERK磷酸化可缓解银屑病样瘙痒。
临床怎么用
- 提示IL-17R/ERK/TRPV4通路可作为银屑病瘙痒的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Itch represents a major disease burden of psoriasis. Despite recent clinical studies showing the effectiveness of IL-17- and IL-17R-blocking antibodies in alleviating psoriatic itch, significant questions remain unanswered. Specifically, the crucial cellular site of action and the impacted signaling pathway of IL-17/IL-17R in psoriatic itch are elusive. Itch sensation relies on dorsal root ganglion (DRG) sensory neurons that transmit pruriceptive signals from the periphery to the CNS. IL-17RA and IL-17RC, 2 cognate receptors for IL-17, are expressed in DRG neurons. In this study, we demonstrated that IL-17RA and IL-17RC are upregulated in DRG neurons in a mouse model of psoriasis induced by imiquimod. Notably, conditional knockout of Il17ra or Il17rc in sensory neurons potently attenuated psoriasis-like itch. Furthermore, our in vitro assay with cultured neurons and in vivo experiment with animal model of psoriasis demonstrated that IL-17RA and IL-17RC upregulate the pruritic ion channel TRPV4 in DRG neurons through the extracellular signal-regulated kinase (ERK) signaling pathway. Specific deletion of Trpv4 or suppression of phosphorylation of ERK in DRG neurons mitigated psoriasis-like itch. These findings suggest that the IL-17R/ERK/TRPV4 signaling pathway in sensory neurons plays a significant role in psoriatic itch.
引用
- Zhang Q, Jang M, Dias FC, et al. Neuronal Mechanisms of Psoriatic Itch: Role of IL-17R/ERK/TRPV4 Signaling Pathway. J Invest Dermatol. 2025. PMID: 40252992. doi:10.1016/j.jid.2025.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。